HCPCS Level II › C
HCPCS Level II codes starting with C
622 codes, page 6 of 7. Every code ever valid for billing is listed, including those now retired.
| Code | Description | Status |
|---|---|---|
| C9473 | Injection, mepolizumab, 1 mg through FY2026 | Terminated |
| C9474 | Injection, irinotecan liposome, 1 mg through FY2026 | Terminated |
| C9475 | Injection, necitumumab, 1 mg through FY2026 | Terminated |
| C9476 | Injection, daratumumab, 10 mg through FY2026 | Terminated |
| C9477 | Injection, elotuzumab, 1 mg through FY2026 | Terminated |
| C9478 | Injection, sebelipase alfa, 1 mg through FY2026 | Terminated |
| C9479 | Instillation, ciprofloxacin otic suspension, 6 mg through FY2026 | Terminated |
| C9480 | Injection, trabectedin, 0.1 mg through FY2026 | Terminated |
| C9481 | Injection, reslizumab, 1 mg through FY2026 | Terminated |
| C9482 | Injection, sotalol hydrochloride, 1 mg | Valid |
| C9483 | Injection, atezolizumab, 10 mg through FY2026 | Terminated |
| C9484 | Injection, eteplirsen, 10 mg through FY2026 | Terminated |
| C9485 | Injection, olaratumab, 10 mg through FY2026 | Terminated |
| C9486 | Injection, granisetron extended release, 0.1 mg through FY2026 | Terminated |
| C9487 | Ustekinumab, for intravenous injection, 1 mg through FY2026 | Terminated |
| C9488 | Injection, conivaptan hydrochloride, 1 mg | Valid |
| C9489 | Injection, nusinersen, 0.1 mg through FY2026 | Terminated |
| C9490 | Injection, bezlotoxumab, 10 mg through FY2026 | Terminated |
| C9491 | Injection, avelumab, 10 mg through FY2026 | Terminated |
| C9492 | Injection, durvalumab, 10 mg through FY2026 | Terminated |
| C9493 | Injection, edaravone, 1 mg through FY2026 | Terminated |
| C9494 | Injection, ocrelizumab, 1 mg through FY2026 | Terminated |
| C9497 | Loxapine, inhalation powder, 10 mg through FY2026 | Terminated |
| C9507 | Plasma, high titer covid-19 convalescent, each unit | Valid |
| C9600 | Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch | Valid |
| C9601 | Percutaneous transcatheter placement of drug-eluting intracoronary stent(s), with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure) | Valid |
| C9602 | Percutaneous transluminal coronary atherectomy, with drug eluting intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch | Valid |
| C9603 | Percutaneous transluminal coronary atherectomy, with drug-eluting intracoronary stent, with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure) | Valid |
| C9604 | Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; single vessel | Valid |
| C9605 | Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; each additional branch subtended by the bypass graft (list separately in addition to code for primary procedure) | Valid |
| C9606 | Percutaneous transluminal revascularization of acute total/subtotal occlusion during acute myocardial infarction, coronary artery or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including aspiration thrombectomy when performed, single vessel | Valid |
| C9607 | Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; single vessel | Valid |
| C9608 | Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; each additional coronary artery, coronary artery branch, or bypass graft (list separately in addition to code for primary procedure) | Valid |
| C9610 | Catheter, transluminal drug delivery with or without angioplasty, coronary, non-laser (insertable) | Valid |
| C9724 | Endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopy through FY2026 | Terminated |
| C9725 | Placement of endorectal intracavitary applicator for high intensity brachytherapy | Valid |
| C9726 | Placement and removal (if performed) of applicator into breast for intraoperative radiation therapy, add-on to primary breast procedure | Valid |
| C9727 | Insertion of implants into the soft palate; minimum of three implants | Valid |
| C9728 | Placement of interstitial device(s) for radiation therapy/surgery guidance (e.g., fiducial markers, dosimeter), for other than the following sites (any approach): abdomen, pelvis, prostate, retroperitoneum, thorax, single or multiple | Valid |
| C9733 | Non-ophthalmic fluorescent vascular angiography | Valid |
| C9734 | Focused ultrasound ablation/therapeutic intervention, other than uterine leiomyomata, with magnetic resonance (mr) guidance | Valid |
| C9735 | Anoscopy; with directed submucosal injection(s), any substance through FY2026 | Terminated |
| C9737 | Laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band) through FY2026 | Terminated |
| C9738 | Adjunctive blue light cystoscopy with fluorescent imaging agent (list separately in addition to code for primary procedure) | Valid |
| C9739 | Cystourethroscopy, with insertion of transprostatic implant; 1 to 3 implants | Valid |
| C9740 | Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants | Valid |
| C9741 | Right heart catheterization with implantation of wireless pressure sensor in the pulmonary artery, including any type of measurement, angiography, imaging supervision, interpretation, and report through FY2026 | Terminated |
| C9742 | Laryngoscopy, flexible fiberoptic, with injection into vocal cord(s), therapeutic, including diagnostic laryngoscopy, if performed through FY2026 | Terminated |
| C9743 | Injection/implantation of bulking or spacer material (any type) with or without image guidance (not to be used if a more specific code applies) through FY2026 | Terminated |
| C9744 | Ultrasound, abdominal, with contrast through FY2026 | Terminated |
| C9745 | Nasal endoscopy, surgical; balloon dilation of eustachian tube through FY2026 | Terminated |
| C9746 | Transperineal implantation of permanent adjustable balloon continence device, with cystourethroscopy, when performed and/or fluoroscopy, when performed through FY2026 | Terminated |
| C9747 | Ablation of prostate, transrectal, high intensity focused ultrasound (hifu), including imaging guidance through FY2026 | Terminated |
| C9748 | Transurethral destruction of prostate tissue; by radiofrequency water vapor (steam) thermal therapy through FY2026 | Terminated |
| C9749 | Repair of nasal vestibular lateral wall stenosis with implant(s) through FY2026 | Terminated |
| C9750 | Insertion or removal and replacement of intracardiac ischemia monitoring system including imaging supervision and interpretation and peri-operative interrogation and programming; complete system (includes device and electrode) through FY2026 | Terminated |
| C9751 | Bronchoscopy, rigid or flexible, transbronchial ablation of lesion(s) by microwave energy, including fluoroscopic guidance, when performed, with computed tomography acquisition(s) and 3-d rendering, computer-assisted, image-guided navigation, and endobronchial ultrasound (ebus) guided transtracheal and/or transbronchial sampling (e.g., aspiration[s]/biopsy[ies]) and all mediastinal and/or hilar lymph node stations or structures and therapeutic intervention(s) through FY2026 | Terminated |
| C9752 | Destruction of intraosseous basivertebral nerve, first two vertebral bodies, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum through FY2026 | Terminated |
| C9753 | Destruction of intraosseous basivertebral nerve, each additional vertebral body, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum (list separately in addition to code for primary procedure) through FY2026 | Terminated |
| C9754 | Creation of arteriovenous fistula, percutaneous; direct, any site, including all imaging and radiologic supervision and interpretation, when performed and secondary procedures to redirect blood flow (e.g., transluminal balloon angioplasty, coil embolization, when performed) through FY2026 | Terminated |
| C9755 | Creation of arteriovenous fistula, percutaneous using magnetic-guided arterial and venous catheters and radiofrequency energy, including flow-directing procedures (e.g., vascular coil embolization with radiologic supervision and interpretation, when performed) and fistulogram(s), angiography, venography, and/or ultrasound, with radiologic supervision and interpretation, when performed through FY2026 | Terminated |
| C9756 | Intraoperative near-infrared fluorescence lymphatic mapping of lymph node(s) (sentinel or tumor draining) with administration of indocyanine green (icg) (list separately in addition to code for primary procedure) | Valid |
| C9757 | Laminotomy (hemilaminectomy), with decompression of nerve root(s), including partial facetectomy, foraminotomy and excision of herniated intervertebral disc, and repair of annular defect with implantation of bone anchored annular closure device, including annular defect measurement, alignment and sizing assessment, and image guidance; 1 interspace, lumbar | Valid |
| C9758 | Blinded procedure for nyha class iii/iv heart failure; transcatheter implantation of interatrial shunt or placebo control, including right heart catheterization, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study | Valid |
| C9759 | Transcatheter intraoperative blood vessel microinfusion(s) (e.g., intraluminal, vascular wall and/or perivascular) therapy, any vessel, including radiological supervision and interpretation, when performed | Valid |
| C9760 | Non-randomized, non-blinded procedure for nyha class ii, iii, iv heart failure; transcatheter implantation of interatrial shunt, including right and left heart catheterization, transeptal puncture, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study | Valid |
| C9761 | Cystourethroscopy, with ureteroscopy and/or pyeloscopy, with lithotripsy, and ureteral catheterization for steerable vacuum aspiration of the kidney, collecting system, ureter, bladder, and urethra if necessary, with use of steerable ureteral catheter or suction-integrated ureteroscope | Valid |
| C9762 | Cardiac magnetic resonance imaging for morphology and function, quantification of segmental dysfunction; with strain imaging | Valid |
| C9763 | Cardiac magnetic resonance imaging for morphology and function, quantification of segmental dysfunction; with stress imaging | Valid |
| C9764 | Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy, includes angioplasty within the same vessel(s), when performed | Valid |
| C9765 | Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy, and transluminal stent placement(s), includes angioplasty within the same vessel(s), when performed | Valid |
| C9766 | Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy and atherectomy, includes angioplasty within the same vessel(s), when performed | Valid |
| C9767 | Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy and transluminal stent placement(s), and atherectomy, includes angioplasty within the same vessel(s), when performed | Valid |
| C9768 | Endoscopic ultrasound-guided direct measurement of hepatic portosystemic pressure gradient by any method (list separately in addition to code for primary procedure) | Valid |
| C9769 | Cystourethroscopy, with insertion of temporary prostatic implant/stent with fixation/anchor and incisional struts through FY2026 | Terminated |
| C9770 | Vitrectomy, mechanical, pars plana approach, with subretinal injection of pharmacologic/biologic agent through FY2026 | Terminated |
| C9771 | Nasal/sinus endoscopy, cryoablation nasal tissue(s) and/or nerve(s), unilateral or bilateral through FY2026 | Terminated |
| C9772 | Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies), with intravascular lithotripsy, includes angioplasty within the same vessel (s), when performed | Valid |
| C9773 | Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy, and transluminal stent placement(s), includes angioplasty within the same vessel(s), when performed | Valid |
| C9774 | Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy and atherectomy, includes angioplasty within the same vessel (s), when performed | Valid |
| C9775 | Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy and transluminal stent placement(s), and atherectomy, includes angioplasty within the same vessel (s), when performed | Valid |
| C9776 | Intraoperative near-infrared fluorescence imaging of major extra-hepatic bile duct(s) (e.g., cystic duct, common bile duct and common hepatic duct) with intravenous administration of indocyanine green (icg) (list separately in addition to code for primary procedure) | Valid |
| C9777 | Esophageal mucosal integrity testing by electrical impedance, transoral, includes esophagoscopy or esophagogastroduodenoscopy | Valid |
| C9778 | Colpopexy, vaginal; minimally invasive extra-peritoneal approach (sacrospinous) | Valid |
| C9779 | Endoscopic submucosal dissection (esd), including endoscopy or colonoscopy, mucosal closure, when performed | Valid |
| C9780 | Insertion of central venous catheter through central venous occlusion via inferior and superior approaches (e.g., inside-out technique), including imaging guidance | Valid |
| C9781 | Arthroscopy, shoulder, surgical; with implantation of subacromial spacer (e.g., balloon), includes debridement (e.g., limited or extensive), subacromial decompression, acromioplasty, and biceps tenodesis when performed | Valid |
| C9782 | Blinded procedure for new york heart association (nyha) class ii or iii heart failure, or canadian cardiovascular society (ccs) class iii or iv chronic refractory angina; transcatheter intramyocardial transplantation of autologous bone marrow cells (e.g., mononuclear) or placebo control, autologous bone marrow harvesting and preparation for transplantation, left heart catheterization including ventriculography, all laboratory services, and all imaging with or without guidance (e.g., transthoracic echocardiography, ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study | Valid |
| C9783 | Blinded procedure for transcatheter implantation of coronary sinus reduction device or placebo control, including vascular access and closure, right heart catheterization, venous and coronary sinus angiography, imaging guidance and supervision and interpretation when performed in an approved investigational device exemption (ide) study | Valid |
| C9784 | Gastric restrictive procedure, endoscopic sleeve gastroplasty, with esophagogastroduodenoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components through FY2026 | Terminated |
| C9785 | Endoscopic outlet reduction, gastric pouch application, with endoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components | Valid |
| C9786 | Echocardiography image post processing for computer aided detection of heart failure with preserved ejection fraction, including interpretation and report through FY2026 | Terminated |
| C9787 | Gastric electrophysiology mapping with simultaneous patient symptom profiling through FY2026 | Terminated |
| C9788 | Opto-acoustic imaging, breast (including axilla when performed), unilateral, with image documentation, analysis and report, obtained with ultrasound examination through FY2026 | Terminated |
| C9789 | Instillation of anti-neoplastic pharmacologic/biologic agent into renal pelvis, any method, including all imaging guidance, including volumetric measurement if performed | Valid |
| C9790 | Histotripsy (i.e., non-thermal ablation via acoustic energy delivery) of malignant renal tissue, including image guidance through FY2026 | Terminated |
| C9791 | Magnetic resonance imaging with inhaled hyperpolarized xenon-129 contrast agent, chest, including preparation and administration of agent | Valid |
| C9792 | Blinded or nonblinded procedure for symptomatic new york heart association (nyha) class ii, iii, iva heart failure; transcatheter implantation of left atrial to coronary sinus shunt using jugular vein access, including all imaging necessary to intra procedurally map the coronary sinus for optimal shunt placement (e.g., tee or ice ultrasound, fluoroscopy), performed under general anesthesia in an approved investigational device exemption (ide) study) | Valid |
| C9793 | 3d predictive model generation for pre-planning of a cardiac procedure, using data from cardiac computed tomographic angiography and/or magnetic resonance imaging with report | Valid |
| C9794 | Therapeutic radiology simulation-aided field setting; complex, including acquisition of pet and ct imaging data required for radiopharmaceutical-directed radiation therapy treatment planning (i.e., modeling) through FY2026 | Terminated |